Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 102021
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102021
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102021
Chronic myelogenous leukemia secondary to colon cancer: A case report
Xiao-Lan Li, Hua Yang, Juan Tian, Zi-Wei Shi, Kui Song, Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou 416000, Hunan Province, China
Min Li, Ling-Zhi Wang, Department of Pharmacy, The First Affiliated Hospital of Jishou University, Jishou 416000, Hunan Province, China
Author contributions: Song K and Li XL conceived and designed the study; Li XL collected all relevant data of patients from the database and drafted the manuscript; Li M was responsible for medication guidance; Shi ZW and Wang LZ analyzed the data. Song K revised the manuscript; Yang H and Tian J participated in making the pathological diagnosis; and all authors confirmed the authenticity of all the raw data, and have read and approved the final manuscript.
Supported by the Innovation Platform and talent program of Hunan Province, No. 2021SK4050; and the Natural Science Foundation of Hunan Province, No. 2023JJ30608 and No. 2023JJ30609.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kui Song, Professor, Department of Hematology, The First Affiliated Hospital of Jishou University, No. 26 Century Avenue, Qianzhou, Jishou 416000, Hunan Province, China. songkui2001@163.com
Received: October 5, 2024
Revised: January 26, 2025
Accepted: February 18, 2025
Published online: April 15, 2025
Processing time: 171 Days and 0.9 Hours
Revised: January 26, 2025
Accepted: February 18, 2025
Published online: April 15, 2025
Processing time: 171 Days and 0.9 Hours
Core Tip
Core Tip: We report a case of chronic myelogenous leukemia secondary to colon cancer. Secondary hematological tumors may be multifactorial, and the exact mechanism is currently unknown. Owing to the slow progression of the disease, patients with chronic myelogenous leukemia show no symptoms in the early stage. However, with disease progression, obvious but non-specific symptoms may appear, including fever, anemia, bleeding tendency, and hypertrophy. Therefore, complete blood count monitoring for routine examination is recommended after cancer treatment for early detection of occult hematological tumors.